910
Vol. 60, No. 7
The oxazolones were purified by column chromatography
for analysis, with some losses.
1
IR, MS, and H-NMR spectra of all oxazolones were con-
sistent with the literature.
4-Isobutyl-2-phenyloxazol-5(4H)-one (4a)5,6,20,27): Colorless
1
°
crystals. mp 55–57 C. H-NMR (CDCl3) δ: 8.02–7.98 (2H, m),
7.61–7.46 (3H, m), 4.42 (1H, dd, J=5.5, 9.0Hz), 2.07 (1H, m),
1.89–1.80 (1H, m), 1.73–1.64 (1H, m), 1.04 (3H, d, J=6.5Hz),
1.01 (3H, d, J=6.5Hz). IR (CHCl3) cm−1: 1824, 1655. High
resolution (HR)-MS (EI) m/z: 217.1111 [Calcd for C13H15NO2:
217.1097 (M+)].
4-[(1S)-1-Methylpropyl]-2-phenyl-oxazol-5(4H)-one (4b)5):
Colorless oil (a mixture of diastereomers, whose ratio was
found to be changed from 1:1 to 9:10 [=(SS):(RS)], after
1
purification by silica-gel column chromatography). H-NMR
(CDCl3) for the SS isomer: δ: 8.03–7.99 (2H, m), 7.60–7.55
(1H, m), 7.52–7.46 (2H, m), 4.37 (1H, d, J=4.7Hz), 2.20–2.09
(1H, m), 1.62–1.52 (1H, m), 1.44–1.34 (1H, m), 1.07 (3H, d,
1
J=6.9Hz), 0.97 (3H, t, J=7.4Hz). H-NMR (CDCl3) for the
a) i) DMT-MM (1.05eq), N-methylmorpholine (0.20eq), acetone/H2O (3:1),
RS isomer δ: 8.03–7.99 (2H, m), 7.60–7.55 (1H, m), 7.52–7.46
(2H, m), 4.42 (1H, d, J=4.0Hz), 2.20–2.09 (1H, m), 1.75–1.64
(1H, m), 1.52–1.40 (1H, m), 1.02 (3H, t, J=7.3Hz), 0.91 (3H,
d, J=6.9Hz). IR (CHCl3) cm−1: 1820, 1653. HR-MS (EI) m/z:
217.1107 [Calcd for C13H15NO2: 217.1103 (M+)].
rt, 15min; ii) L-alanine (1.1eq), NaOH (1.1eq), acetone/H2O (1:1), rt, 13h; iii)
DMT-MM (3.5eq), N-methylmorpholine (2.0eq), CH2Cl2/acetone/H2O (1:1:1),
rt, 6h, 80%. b) i) DMT-MM (1.05eq), N-methylmorpholine (0.20eq), acetone/
H2O (3:1), rt, 15min; ii) DL-2-phenylglycine (1.1eq), NaOH (1.1eq), acetone/H2O
(1:1), rt, 60h; iii) DMT-MM (2.1eq), CH2Cl2/acetone/H2O (1:1:1), rt, 2h, 57%.
Chart 3. One-Pot Synthesis of Oxazole Derivatives
4-Isopropyl-2-phenyloxazol-5(4H)-one (4c)5,6,20,27)
:
Color-
°
to synthetically useful oxazolones.
less crystals. mp 49–52 C. 1H-NMR (CDCl3) δ: 8.04–8.00
(2H, m), 7.61–7.55 (1H, m), 7.52–7.47 (2H, m), 4.30 (1H, d,
J=4.7Hz), 2.46–2.33 (1H, m), 1.15 (3H, d, J=7.0Hz), 1.03 (3H,
Experimental
General Methods 1H-NMR spectra were recorded on a d, J=7.0Hz). IR (CHCl3) cm−1: 1820, 1655. HR-MS (EI) m/z:
JEOL JNM-ECS400 and a JNM-ECS600 spectrometer. 13C- 203.0943 [Calcd for C12H13NO2: 203.094 (M+)].
NMR spectra were recorded on a JEOL JNM-ECS400 spec-
4-Benzyl-2-phenyloxazol-5(4H)-one (4d)5,6,14,20,27)
:
White
1
°
trometer. Chemical shifts are reported as δ values relative to solid. mp 72–74 C. H-NMR (CDCl3) δ: 7.94–7.90 (2H, m),
tetramethylsilane as internal standard. Infrared spectra were 7.57–7.52 (1H, m), 7.48–7.42 (2H, m), 7.29–7.17 (5H, m), 4.69
recorded on a HORIBA FT-720 FREEXACT-II spectrom- (1H, dd, J=5.0, 7.0Hz), 3.37 (1H, dd, J=5.0, 14.0Hz), 3.19
eter. Mass spectra were measured on a JEOL JMS-SX102A (1H, dd, J=7.0, 14.0Hz). IR (CHCl3) cm−1: 1821, 1657. HR-MS
(electron ionization (EI)-MS and FAB-MS) spectrometer. El- (EI) m/z: 251.0949 [Calcd for C16H13NO2: 251.0941 (M+)].
emental analyses were carried out with a Yanaco CHN Corder
MT-5 instrument.
4-[2-(Methylsulfanyl)ethyl]-2-phenyloxazol-5(4H)-one
1
(4e)5,20): Colorless oil. H-NMR (CDCl3) δ: 8.02–7.98 (2H, m),
DMT-MM was prepared from 2-chloro-4,6-dimethoxy- 7.61–7.56 (1H, m), 7.52–7.46 (2H, m), 4.61 (1H, dd, J=6.0,
1,3,5-triazine (CDMT) and N-methylmorpholine according to 7.5Hz), 2.74 (2H, t, J=7.1Hz), 2.37–2.27 (1H, m), 2.20–2.09
the literature procedure.6) N,N-Diethylaniline hydrochloride (1H, m), 2.12 (3H, s). IR (CHCl3) cm−1: 1828, 1653. HR-MS
was prepared from N,N-diethylaniline and concentrated HCl. (EI) m/z: 235.0661 [Calcd for C12H13NO2: 235.0662 (M+)].
Other chemicals were obtained from commercial sources and
used as received unless otherwise noted.
4-[(1H-Indol-3-yl)methyl]-2-phenyloxazol-5(4H)-one (4f)5):
1
°
Colorless crystals. mp 148–149 C. H-NMR (CDCl3) δ: 8.01
General Procedure for Preparation of Oxazolones (1H, brs), 7.91–7.86 (2H, m), 7.74–7.70 (1H, m), 7.55–7.49 (1H,
DMT-MM (0.525mmol) was added to a solution of carbox- m), 7.45–7.39 (2H, m), 7.32–7.28 (1H, m), 7.18–7.09 (3H, m),
ylic acid (0.500mmol) and N-methylmorpholine (0.10mmol) 4.76 (1H, dd, J=5.0, 6.1Hz), 3.53 (1H, dd, J=5.0, 14.8Hz),
in acetone/H2O (1.67mL:0.56mL) at room temperature. After 3.41 (1H, dd, J=6.1, 14.8Hz). IR (CHCl3) cm−1: 1817, 1655.
stirring 15–30min, a solution of amino acid (0.550mmol) and HR-MS (EI) m/z: 290.1057 [Calcd for C18H14N2O2: 290.1050
sodium hydroxide (0.55mmol) in water (1.11mL) was added, (M+)].
and the mixture was stirred at room temperature. After the
4-Methyl-2-phenyloxazol-5(4H)-one (4g)5,6,14,20,27)
:
White
reaction was completed (monitored by TLC), dichloromethane solid. mp 44 C. 1H-NMR (CDCl3) δ: 8.03–7.98 (2H, m),
(1.67mL), N,N-diethylaniline hydrochloride (0.650mmol) and 7.61–7.56 (1H, m), 7.53–7.47 (2H, m), 4.46 (1H, q, J=7.6Hz),
DMT-MM (0.550mmol) were added in order, and the mixture 1.60 (3H, d, J=7.6Hz). IR (CHCl3) cm−1: 1817, 1655. HR-MS
was stirred for 2–8h at room temperature. The reaction mix- (EI) m/z: 175.0635 [Calcd for C10H9NO2: 175.0628 (M+)].
°
ture was poured into an organic solvent (hexane, EtOAc, or
4-Methyl-2-(naphthalen-1-yl)oxazol-5(4H)-one (4h)5): White
hexane/EtOAc) (30mL), successively washed with water twice solid. mp 87–88 C. 1H-NMR (CDCl3) δ: 9.26 (1H, d,
(30, 10mL), aqueous 1M HCl twice (30, 10mL), water (10mL), J=8.8Hz), 8.17 (1H, dd, J=1.2, 8.1Hz), 8.05 (1H, d, J=8.1Hz),
saturated aqueous NaCl (10mL). The organic layer was dried 7.92 (1H, d, J=8.0Hz), 7.69–7.64 (1H, m), 7.61–7.54 (2H, m),
over MgSO4, filtered, and the solvent was evaporated under 4.62 (1H, q, J=7.5Hz), 1.69 (3H, d, J=7.9Hz). IR (CHCl3)
°
reduced pressure to give oxazolone 4a–i.
cm−1: 1817, 1647. HR-MS (EI) m/z: 225.0789 [Calcd for